Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP221615.RA8m0xWimlFNl0FkQNWApXf3BUvEKrezs9U6vJOGekcA8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP221615.RA8m0xWimlFNl0FkQNWApXf3BUvEKrezs9U6vJOGekcA8130_assertion type Assertion NP221615.RA8m0xWimlFNl0FkQNWApXf3BUvEKrezs9U6vJOGekcA8130_head.
- NP221615.RA8m0xWimlFNl0FkQNWApXf3BUvEKrezs9U6vJOGekcA8130_assertion description "[However, as results of TPO-RT-PCR correlate significantly with lymph node status, grading and serum TG measurements in patients with non-metastatic disease, TPO seems to be an interesting molecular marker to look at in follow-up studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221615.RA8m0xWimlFNl0FkQNWApXf3BUvEKrezs9U6vJOGekcA8130_provenance.
- NP221615.RA8m0xWimlFNl0FkQNWApXf3BUvEKrezs9U6vJOGekcA8130_assertion evidence source_evidence_literature NP221615.RA8m0xWimlFNl0FkQNWApXf3BUvEKrezs9U6vJOGekcA8130_provenance.
- NP221615.RA8m0xWimlFNl0FkQNWApXf3BUvEKrezs9U6vJOGekcA8130_assertion SIO_000772 12459031 NP221615.RA8m0xWimlFNl0FkQNWApXf3BUvEKrezs9U6vJOGekcA8130_provenance.
- NP221615.RA8m0xWimlFNl0FkQNWApXf3BUvEKrezs9U6vJOGekcA8130_assertion wasDerivedFrom befree-20140225 NP221615.RA8m0xWimlFNl0FkQNWApXf3BUvEKrezs9U6vJOGekcA8130_provenance.
- NP221615.RA8m0xWimlFNl0FkQNWApXf3BUvEKrezs9U6vJOGekcA8130_assertion wasGeneratedBy ECO_0000203 NP221615.RA8m0xWimlFNl0FkQNWApXf3BUvEKrezs9U6vJOGekcA8130_provenance.